Answer
No, safety and efficacy of the MSN Laboratories Europe Ltd olmesartan medoxomil/hydrochlorothiazide 20 mg/12.5 mg and 20 mg/25 mg film-coated tablet products have not been established in children and adolescents below 18 years, and no data are available.
Sources for this answer
- Olmesartan medoxomil/Hydrochlorothiazide 20 mg/12.5 mg and 20 mg/25 mg film-coated tabletsMSN Laboratories Europe Ltd · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked